162 related articles for article (PubMed ID: 12149649)
41. Protein kinase CK2 in mammary gland tumorigenesis.
Landesman-Bollag E; Romieu-Mourez R; Song DH; Sonenshein GE; Cardiff RD; Seldin DC
Oncogene; 2001 May; 20(25):3247-57. PubMed ID: 11423974
[TBL] [Abstract][Full Text] [Related]
42. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.
Vilk G; Saulnier RB; St Pierre R; Litchfield DW
J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865
[TBL] [Abstract][Full Text] [Related]
43. Toward the rational design of protein kinase casein kinase-2 inhibitors.
Sarno S; Moro S; Meggio F; Zagotto G; Dal Ben D; Ghisellini P; Battistutta R; Zanotti G; Pinna LA
Pharmacol Ther; 2002; 93(2-3):159-68. PubMed ID: 12191608
[TBL] [Abstract][Full Text] [Related]
44. [Protein kinase CK2 and cancer: further clues are accumulating].
Filhol O; Cochet C
Bull Cancer; 2002 Mar; 89(3):261-5. PubMed ID: 11940465
[TBL] [Abstract][Full Text] [Related]
45. Murine protein kinase CK2: gene and oncogene.
Xu X; Landesman-Bollag E; Channavajhala PL; Seldin DC
Mol Cell Biochem; 1999 Jan; 191(1-2):65-74. PubMed ID: 10094394
[TBL] [Abstract][Full Text] [Related]
46. c-Raf kinase binds to N-terminal domain of c-Myc.
Alexandrov I; Shlyakhova L; Vartanian A; Zajac-Kaye M; Alexandrova N
FEBS Lett; 1997 Sep; 414(2):465-70. PubMed ID: 9315742
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis.
Yamada M; Katsuma S; Adachi T; Hirasawa A; Shiojima S; Kadowaki T; Okuno Y; Koshimizu TA; Fujii S; Sekiya Y; Miyamoto Y; Tamura M; Yumura W; Nihei H; Kobayashi M; Tsujimoto G
Proc Natl Acad Sci U S A; 2005 May; 102(21):7736-41. PubMed ID: 15897466
[TBL] [Abstract][Full Text] [Related]
48. The catalytic subunit of protein kinase CK2 phosphorylates in vitro the movement protein of Tomato mosaic virus.
Matsushita Y; Ohshima M; Yoshioka K; Nishiguchi M; Nyunoya H
J Gen Virol; 2003 Feb; 84(Pt 2):497-505. PubMed ID: 12560584
[TBL] [Abstract][Full Text] [Related]
49. p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.
Keller DM; Lu H
J Biol Chem; 2002 Dec; 277(51):50206-13. PubMed ID: 12393879
[TBL] [Abstract][Full Text] [Related]
50. CK2 enzyme affinity against c-myc 424-434 substrate in human lung cancer tissue.
Yaylim I; Ozkan NE; Isitmangil T; Isitmangil G; Turna A; Isbir T
Asian Pac J Cancer Prev; 2012; 13(10):5233-6. PubMed ID: 23244141
[TBL] [Abstract][Full Text] [Related]
51. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
Daniel CJ; Pelz C; Wang X; Munks MW; Ko A; Murugan D; Byers SA; Juarez E; Taylor KL; Fan G; Coussens LM; Link JM; Sears RC
Mol Cancer Res; 2022 Jul; 20(7):1151-1165. PubMed ID: 35380701
[TBL] [Abstract][Full Text] [Related]
52. Protein Kinase CK2 Controls CD8
Yang W; Wei H; Benavides GA; Turbitt WJ; Buckley JA; Ouyang X; Zhou L; Zhang J; Harrington LE; Darley-Usmar VM; Qin H; Benveniste EN
J Immunol; 2022 Sep; 209(5):896-906. PubMed ID: 35914835
[TBL] [Abstract][Full Text] [Related]
53. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
Battistutta R; De Moliner E; Sarno S; Zanotti G; Pinna LA
Protein Sci; 2001 Nov; 10(11):2200-6. PubMed ID: 11604527
[TBL] [Abstract][Full Text] [Related]
54. FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction.
Guerra B; Boldyreff B; Issinger OG
Int J Oncol; 2001 Dec; 19(6):1117-26. PubMed ID: 11713579
[TBL] [Abstract][Full Text] [Related]
55. Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.
Nelson N; Szekeres K; Iclozan C; Rivera IO; McGill A; Johnson G; Nwogu O; Ghansah T
PLoS One; 2017; 12(2):e0170197. PubMed ID: 28152014
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase.
Yang D; Liu H; Goga A; Kim S; Yuneva M; Bishop JM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13836-41. PubMed ID: 20643922
[TBL] [Abstract][Full Text] [Related]
57. The ornithine decarboxylase inhibitor, difluoromethylornithine, inhibits casein kinase II activity, c-Myc expression and normal human keratinocyte proliferation.
Praskova M; Kalenderova S; Miteva L; Poumay Y; Mitev V
Arch Dermatol Res; 2002 Jan; 293(11):590-3. PubMed ID: 11876528
[No Abstract] [Full Text] [Related]
58. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.
Battistutta R; Sarno S; De Moliner E; Papinutto E; Zanotti G; Pinna LA
J Biol Chem; 2000 Sep; 275(38):29618-22. PubMed ID: 10882732
[TBL] [Abstract][Full Text] [Related]
59. Activation of human topoisomerase I by protein kinase CK2.
Kowalska-Loth B; Girstun A; Derlacz R; StaroĊ K
Mol Biol Rep; 2003 Jun; 30(2):107-11. PubMed ID: 12841581
[TBL] [Abstract][Full Text] [Related]
60. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle.
Seldin DC; Leder P
Science; 1995 Feb; 267(5199):894-7. PubMed ID: 7846532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
